Matches in Wikidata for { <http://www.wikidata.org/entity/Q67129811> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q67129811 description "clinical trial" @default.
- Q67129811 description "ensayu clínicu" @default.
- Q67129811 description "клінічне випробування" @default.
- Q67129811 name "Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)" @default.
- Q67129811 type Item @default.
- Q67129811 label "Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)" @default.
- Q67129811 prefLabel "Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)" @default.
- Q67129811 P1050 Q67129811-4825CBF1-2886-42C6-A314-641978250CC8 @default.
- Q67129811 P1050 Q67129811-B78C66C2-BE35-439E-9554-758F73A9DB2E @default.
- Q67129811 P1050 Q67129811-DB286ECA-F55C-4D9C-984C-4797EC75C683 @default.
- Q67129811 P1132 Q67129811-1442FBAE-9FE0-4646-97D9-EC51B1F575E3 @default.
- Q67129811 P1476 Q67129811-281F6610-DF41-4704-9459-784CB8B3E2E9 @default.
- Q67129811 P2899 Q67129811-B9CB1011-C3C6-4092-965F-0180BA9DD5EA @default.
- Q67129811 P3098 Q67129811-1FE0367F-101E-4E6C-BC69-85DA03B185C0 @default.
- Q67129811 P31 Q67129811-15899AF9-F79C-4CB8-ACAA-444F94CA1A07 @default.
- Q67129811 P4844 Q67129811-70CCF694-B5CE-4218-81DB-CEB1F52662CE @default.
- Q67129811 P580 Q67129811-5DFF0E11-54C6-4743-8337-E5C19B461146 @default.
- Q67129811 P582 Q67129811-EF907993-3A66-4B8B-B7A4-FE6FCF01F6F5 @default.
- Q67129811 P6099 Q67129811-4BAC8DE2-86AA-4DB6-8733-AD7B10EA42FA @default.
- Q67129811 P8363 Q67129811-AB0934FA-B5D5-481B-9B04-CCAC8C93F871 @default.
- Q67129811 P1050 Q131742 @default.
- Q67129811 P1050 Q154869 @default.
- Q67129811 P1050 Q157661 @default.
- Q67129811 P1132 "+94" @default.
- Q67129811 P1476 "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (MK-5172 + MK-3682 + MK-8408 Fixed Dose Combination (FDC)) in Subjects With Chronic HCV GT1 or GT3 Infection Who Have Failed a Direct Acting Antiviral Regimen" @default.
- Q67129811 P2899 "+18" @default.
- Q67129811 P3098 "NCT02613403" @default.
- Q67129811 P31 Q30612 @default.
- Q67129811 P4844 Q27281714 @default.
- Q67129811 P580 "2015-12-10T00:00:00Z" @default.
- Q67129811 P582 "2017-01-09T00:00:00Z" @default.
- Q67129811 P6099 Q42824440 @default.
- Q67129811 P8363 Q78089383 @default.